Identifikatu
Taldeak
Ikertzaileak
Emaitzak
HOSPITAL UNIVERSITARIO RUBER
Saila
French Institute of Health and Medical Research
París, Francia
Hemen zaude
Lankidetzak
French Institute of Health and Medical Research
French Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
The Lancet, Vol. 403, Núm. 10437, pp. 1649-1659
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de